Correlation Between Viridian Therapeutics and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Emergent Biosolutions, you can compare the effects of market volatilities on Viridian Therapeutics and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Emergent Biosolutions.
Diversification Opportunities for Viridian Therapeutics and Emergent Biosolutions
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viridian and Emergent is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Emergent Biosolutions
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 1.4 times less return on investment than Emergent Biosolutions. But when comparing it to its historical volatility, Viridian Therapeutics is 1.92 times less risky than Emergent Biosolutions. It trades about 0.12 of its potential returns per unit of risk. Emergent Biosolutions is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 728.00 in Emergent Biosolutions on July 17, 2025 and sell it today you would earn a total of 181.00 from holding Emergent Biosolutions or generate 24.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Emergent Biosolutions
Performance |
| Timeline |
| Viridian Therapeutics |
| Emergent Biosolutions |
Viridian Therapeutics and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Emergent Biosolutions
The main advantage of trading using opposite Viridian Therapeutics and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.| Viridian Therapeutics vs. Ventyx Biosciences | Viridian Therapeutics vs. Ideaya Biosciences | Viridian Therapeutics vs. Protagonist Therapeutics | Viridian Therapeutics vs. Verona Pharma PLC |
| Emergent Biosolutions vs. Elanco Animal Health | Emergent Biosolutions vs. SIGA Technologies | Emergent Biosolutions vs. Esperion Therapeutics | Emergent Biosolutions vs. Vir Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |